CUREMARK LLC

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2010–2012

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2012	—	1	1
2011	—	4	1
2010	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
VAN SCOYOC ASSOCIATES	—	7

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	5
SENATE	4
Natl Institutes of Health (NIH)	3

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	6
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	6

Bills Explicitly Cited (5)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2005112th Congress

Combating Autism Reauthorization Act of 2011

2011 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Therapeutic treatment for autism issues generally. H.R.2005/S.1094, Combating Autism Reauthorization Act of 2011, Autism issues. Wound Healing grant issues.

Client expense: — · Firm income: $20,000

Matched citations: H.R.2005

H.R. 3070112th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012

2011 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Monitor H.R.3070/S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2012, Clinical studies for Autism. Monitor Public Law 112-74, Consolidated Appropriations Act, FY2012, Clinical studies for Autism.

Client expense: — · Firm income: $20,000

Matched citations: H.R.3070

S. 1094112th Congress

Combating Autism Reauthorization Act

2011 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Therapeutic treatment for autism issues generally. H.R.2005/S.1094, Combating Autism Reauthorization Act of 2011, Autism issues. Wound Healing grant issues.

Client expense: — · Firm income: $20,000

Matched citations: S.1094

H.R. 2005112th Congress

Combating Autism Reauthorization Act of 2011

2011 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Therapeutic treatment for autism issues generally. H.R.2005/S.1094, Combating Autism Reauthorization Act of 2011, Autism issues. Wound Healing grant issues.

Client expense: — · Firm income: $30,000

Matched citations: H.R.2005

Show 1 more cited filings

S. 1094112th Congress

Combating Autism Reauthorization Act

2011 · third_quarter · Firm: VAN SCOYOC ASSOCIATES

Open original LDA filing ↗

Cited source text and reported amounts

Therapeutic treatment for autism issues generally. H.R.2005/S.1094, Combating Autism Reauthorization Act of 2011, Autism issues. Wound Healing grant issues.

Client expense: — · Firm income: $30,000

Matched citations: S.1094

Source: Senate LDA

CUREMARK LLC — Lobbying Disclosure | Poliscope